Award
Award #75N93026D00021
Long-Term IDV Contract with Utah State University for Antimicrobial Research
Buyer
National Institutes of Health
Award Amount
$2,500.00
Ceiling
$2,500.00
Awarded
September 30, 2026
Period of Performance
Sep 30, 2026 – Sep 29, 2036
Identifier
75N93026D00021
NAICS
541714
This contract is an indefinite delivery vehicle (IDV) awarded to Utah State University, a prominent public research institution. It focuses on the in vitro assessment of antimicrobial activity, a critical area for advancing healthcare and pharmaceutical development. The award represents a long-term commitment by the agency to support scientific research that could lead to improved antimicrobial treatments. The scope of work includes conducting laboratory evaluations to determine antimicrobial effectiveness, providing valuable data to inform drug development and regulatory decisions. This contract was awarded on a competitive basis to leverage the university's expertise in microbiology and biochemistry. The period of performance spans a decade, ensuring sustained research and development efforts. Although modest in initial funding, the agreement lays the foundation for extensive scientific investigation over time.
Description
IN VITRO ASSESSMENT OF ANTIMICROBIAL ACTIVITY (IVAAA)